Breaking News

MilliporeSigma Shares Best Practices and Insights on Bio-Mfg. Topics

To discuss Convergence of IT, OT and Processing Technologies, Capacity Demands, and Facility Intensification

Related CONTENT

04.02.19

Beyond Bioprocessing 4.0: The Convergence of IT, OT and Processing Technologies Today and Tomorrow
April 3, 10:30 a.m. – 11:00 a.m., stage 5, booth #2477
Joshua Hays, senior innovation manager, Software & Automation

Meeting Bioprocessing Manufacturing Capacity Demands – discussing solutions for efficient, cost-effective biologic drug manufacturing – Panel Discussion
April 3, 11:00 a.m. – noon, innovation stage, #1281
Panelist: Mike Felo, Integrated Solutions, BioContinuum™ Platform for Next-Generation Processing

Facility Intensification and Cost Reduction Opportunities using an Integrated Buffer Delivery Platform
April 3, 2:15 p.m. – 3:00 p.m., stage 3, booth #1877
Mike Felo, Integrated Solutions, BioContinuum™ Platform for Next- Generation Processing

Related Searches

Suggested For You

Eurofins PSS Insourcing Solutions

Eurofins PSS Insourcing Solutions

Vetio Animal Health

Vetio Animal Health

Catalent Biologics to Present at INTERPHEX

Catalent Biologics to Present at INTERPHEX

PCI Bolsters Supply Chain Leadership

PCI Bolsters Supply Chain Leadership

Biopharma Contract Fill-and-Finish Market Trends

Biopharma Contract Fill-and-Finish Market Trends

Sartorius, Novasep Enter Bioprocessing Alliance

Sartorius, Novasep Enter Bioprocessing Alliance

WCG Acquires First Clinical Research

WCG Acquires First Clinical Research

Nasal Drug Delivery

Nasal Drug Delivery

FDA & Data Integrity

FDA & Data Integrity

Rentschler Biopharma Appoints Mfg. VP

Rentschler Biopharma Appoints Mfg. VP

Digital Manufacturing a Top Priority for Life Sciences

Digital Manufacturing a Top Priority for Life Sciences

Cobra Biologics, Pall, Cell and Gene Therapy in Continuous Mfg. Tie-up

Cobra Biologics, Pall, Cell and Gene Therapy in Continuous Mfg. Tie-up

Streamlining Drug Development:

Streamlining Drug Development:

Dedicated to Excellence

Dedicated to Excellence

Current market developments and their multifaceted impacts

Current market developments and their multifaceted impacts

Related Breaking News

Breaking News | Facilities | Industry News | Injectables | Parenterals

Civica to Build an Essential Medicines Manufacturing Facility in Virginia

Will produce sterile injectable meds used in hospitals for COVID-19 patient care.
Tim Wright, Editor, Contract Pharma 01.25.21
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News

Humanigen, Emergent Enter Covid-19 Partnership

Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.
Tim Wright, Editor, Contract Pharma 01.25.21
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News

Samsung Bioepis Opens New Headquarters

The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-gen biologic medicines.
Tim Wright, Editor, Contract Pharma 01.25.21
Breaking News | Industry News

Pfizer, BioNTech Enter Vax Pact with COVAX

Initial agreement provides up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine to COVAX in 2021, with first deliveries expected in 1Q21.
Kristin Brooks 01.22.21
Breaking News | Trials & Filings

FDA Approves Janssen’s CABENUVA

Becomes first and only once-monthly, long-acting regimen for the treatment of HIV infection.
Kristin Brooks 01.22.21
Breaking News | Promotions & Moves

AGC Biologics Appoints Boulder Site GM

David Stewart to oversee the startup, strategic development and operational excellence in large-scale biologics production at the Boulder, CO site.
Kristin Brooks 01.22.21
Breaking News | Drug Development | Drug Discovery | Industry News

Lilly Completes $1B Acquisition of Prevail

Adds new modality for drug discovery and development and creates a gene therapy program with neuroscience assets.
Kristin Brooks 01.22.21
Breaking News | Drug Development | Industry News | Information Technology | Regulatory Affairs

Top BioPharma Form Accumulus Synergy

Aims to develop a cloud-based Global Data Sharing Platform to facilitate data and information sharing between industry and health authorities worldwide.
Kristin Brooks 01.22.21
Breaking News | cGMP Manufacture | Industry News

CONTINUUS Awarded $69.3M DoD Grant

Will enable construction of the country's first GMP facility for end-to-end, ICM-driven production of small-molecule drugs in Woburn, MA.
Kristin Brooks 01.22.21
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

AbbVie Licenses ProBioGen’s GlymaxX Technology

Will apply GlymaxX technology to boost the antibody-dependent cell-mediated cytotoxicity (ADCC).
Kristin Brooks 01.22.21
Breaking News | Facilities | Industry News | Logistics | Packaging & Tracking

WDSrx Expands Warehouse Network

Pharma logistics company creates national network with expansion to Reno, NV.
Tim Wright, Editor, Contract Pharma 01.21.21
Aseptic Processing | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Fill/Finish | Industry News

Piramal Inks Clinical Supply Deal with Theratechnologies

CDMO to provide sterile fill/finish drug product formulation and manufacturing from its Lexington, KY facility.
Tim Wright, Editor, Contract Pharma 01.21.21
Breaking News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News

Recipharm Signs Manufacturing Deal with Enzymatica

Agreement will involve an additional Recipharm production site in Pianezza, Italy.
Tim Wright, Editor, Contract Pharma 01.21.21
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News

CDMO Northway Biotech Expands in U.S.

Opens new biopharmaceutical manufacturing site in greater Boston area.
Tim Wright, Editor, Contract Pharma 01.21.21
Breaking News | Industry News | Information Technology | Validation

Global Biosciences Co. Selects ValGenesis VLMS

Will digitize the validation service activities for efficient and faster access to validated and safer products across 40 countries.
Contract Pharma Staff 01.20.21